<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03572309</url>
  </required_header>
  <id_info>
    <org_study_id>CT0022018</org_study_id>
    <nct_id>NCT03572309</nct_id>
  </id_info>
  <brief_title>Incidence of Trauma Induced Coagulopathy in Patients With Prehospital Administration of Fibrinogen</brief_title>
  <acronym>TICAF</acronym>
  <official_title>Incidence of Trauma Induced Coagulopathy in Patients With Prehospital Administration of Fibrinogen</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Masaryk University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brno University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Masaryk University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to find out the incidence of trauma induced coagulopathy in&#xD;
      patients with severe trauma who received fibrinogen prior admission to emergency department&#xD;
      during prehospital care.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will commence following the Approval by The Ethics Research Committee. All patients&#xD;
      admitted to emergency department from the 1st of July 2018 to the 30st of June 2020 will be&#xD;
      enrolled after fulfilling the inclusion criteria and in the absence of any exclusion&#xD;
      criteria. Informed consent will be requested. After admission to emergency department the&#xD;
      blood samples will be taken and blood tests and viscoelastic tests will be performed. All&#xD;
      data and results will be entered in the study form. Statistical analysis will be performed&#xD;
      and incidence of trauma induced coagulopathy estimated. 28-day mortality will be also&#xD;
      monitored.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 23, 2018</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Trauma induced coagulopathy</measure>
    <time_frame>day of enrolment</time_frame>
    <description>Incidence of trauma induced coagulopathy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>28day mortality</measure>
    <time_frame>28 days after enrolment</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Trauma</condition>
  <condition>Hemorrhage</condition>
  <condition>Coagulopathy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult trauma patients with severe trauma admitted to emergency departement of university&#xD;
        hospital who recieved fibrinogen during prehospital care.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  multiple trauma, injury severity score (ISS) â‰¥16&#xD;
&#xD;
          -  administration of fibrinogen in prehospital care&#xD;
&#xD;
          -  age 18-80 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ISS 75&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  therapeutic anticoagulation&#xD;
&#xD;
          -  therapeutic antiaggregation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roman Gal, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Masaryk University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kamil Vrbica, MD</last_name>
    <phone>+420532233850</phone>
    <email>Vrbica.Kamil@fnbrno.cz</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ondrej Hrdy, MD</last_name>
    <phone>+420532233850</phone>
    <email>Hrdy.Ondrej@fnbrno.cz</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Brno and Masaryk University Brno</name>
      <address>
        <city>Brno</city>
        <zip>62500</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kamil Vrbica, M.D.</last_name>
      <phone>532233850</phone>
      <phone_ext>+420</phone_ext>
      <email>vrbica.kamil@fnbrno.cz</email>
    </contact>
    <contact_backup>
      <last_name>Ondrej Hrdy, M.D.</last_name>
      <phone>532232305</phone>
      <phone_ext>+420</phone_ext>
      <email>hrdy.ondrej@fnbrno.cz</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>June 19, 2018</study_first_submitted>
  <study_first_submitted_qc>June 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 28, 2018</study_first_posted>
  <last_update_submitted>March 2, 2021</last_update_submitted>
  <last_update_submitted_qc>March 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>trauma induced coagulopathy</keyword>
  <keyword>multiple trauma</keyword>
  <keyword>fibrinogen</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatic Disorders</mesh_term>
    <mesh_term>Blood Coagulation Disorders</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

